CAPR - CAPRICOR THERAPEUTICS, INC.
IEX Last Trade
12.72
0.220 1.730%
Share volume: 745,175
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
$12.50
-0.47
-0.04%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-05-14 | 2023-08-08 | 2023-11-14 | 2024-11-14 | 2024-05-14 | 2024-08-08 | 2024-11-14 | |
| Assets | ||||||||
| Total Assets | 53.863 M | 46.011 M | 37.152 M | 58.734 M | 49.444 M | 38.277 M | 92.952 M | |
| Current Assets | 46.595 M | 38.925 M | 29.527 M | 50.855 M | 41.412 M | 30.669 M | 85.823 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 547.580 K | 547.580 K | 547.580 K | 10.372 M | 369.000 K | 369.975 K | 409.682 K | |
| Short Term Investments | 34.566 M | 27.956 M | 19.537 M | 24.793 M | 33.702 M | 18.774 M | 16.651 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 10.606 M | 9.837 M | 8.985 M | 14.695 M | 6.215 M | 10.688 M | 68.377 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 4.811 M | 4.790 M | 5.140 M | 5.561 M | 5.894 M | 5.618 M | 5.315 M | |
| Other Assets | 2.190 M | 2.028 M | 2.485 M | 2.050 M | 1.845 M | 1.991 M | 1.813 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 53.863 M | 46.011 M | 37.152 M | 58.734 M | 49.444 M | 38.277 M | 92.952 M | |
| Total liabilities | 47.657 M | 43.280 M | 38.940 M | 36.133 M | 31.010 M | 26.775 M | 24.687 M | |
| Total current liabilities | 37.132 M | 35.154 M | 32.927 M | 31.270 M | 26.384 M | 22.355 M | 20.476 M | |
| Accounts Payable | 5.407 M | 5.134 M | 6.772 M | 6.250 M | 6.249 M | 6.170 M | 6.531 M | |
| Other liabilities | 1.700 M | 1.518 M | 1.684 M | 1.487 M | 1.249 M | 1.044 M | 834.889 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 3.376 M | 3.376 M | 3.376 M | 3.376 M | 3.376 M | 3.376 M | 3.376 M | |
| Other liabilities | 1.700 M | 1.518 M | 1.684 M | 1.487 M | 1.249 M | 1.044 M | 834.889 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 6.206 M | 2.731 M | -1.788 M | 22.601 M | 18.435 M | 11.502 M | 68.265 M | |
| Common stock | 150.959 M | 154.766 M | 156.704 M | 181.733 M | 187.289 M | 191.509 M | 260.887 M | |
| Retained earnings | -144.848 M | -152.215 M | -158.605 M | -159.367 M | -169.161 M | -180.161 M | -192.718 M |